Table 3.
Multivariate analysis for progression free survival in our cohort
| Characteristics | Multivariate analyses | |
|---|---|---|
| HR (95% CI) | P value | |
| Model 1 | ||
| TP53 status | ||
| Mutated | 1.00 (Reference) | |
| Wild type | 0.66 (0.31–1.43) | 0.298 |
| T790M RMA (continuous) | 1.14 (0.49–2.66) | 0.766 |
| T790M RMP (continuous) | 0.15 (0.03–0.79) | 0.025 |
| Model 2 | ||
| TP53 status | ||
| Mutated | 1.00 (Reference) | |
| Wild type | 0.58 (0.28–1.24) | 0.161 |
| T790M RMA (categorical) | ||
| ≤ 0.30 | 1.00 (Reference) | |
| > 0.30 | 0.71 (0.31–1.61) | 0.409 |
| T790M RMP (categorical) | ||
| ≤ 0.24 | 1.00 (Reference) | |
| > 0.24 | 0.46 (0.20–1.05) | 0.066 |
HR hazard ratio, CI confidence interval, RMA Relative mutation abundance, RMP Relative mutation purity